(Q89195822)

English

Long-term safety and efficacy of fasiglifam (TAK-875), a G-protein-coupled receptor 40 agonist, as monotherapy and combination therapy in Japanese patients with type 2 diabetes: a 52-week open-label phase III study

scientific article published on 29 June 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Long-term safety and efficacy of fasiglifam (TAK-875), a G-protein-coupled receptor 40 agonist, as monotherapy and combination therapy in Japanese patients with type 2 diabetes: a 52-week open-label phase III study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

K Kaku

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

K Enya

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

R Nakaya

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

T Ohira

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

R Matsuno

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

publication date

29 June 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

925-929

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1111/J.2040-1124.2012.00207.X

Identifiers

10.1111/DOM.12693

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27178047%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q89195822&oldid=1995915131"